This company discontinued its dividend after 2021.
Based on TTM and annual data · Not a buy/sell signal
This company does not pay dividends
Last dividend was paid in 2021. The company has not paid dividends in the last 4 years.
Does PolyPeptide Group (PPGN.XSWX) pay a dividend?
PolyPeptide Group (PPGN.XSWX) stopped paying a dividend after 2021 and pays nothing today. Free cash flow is currently negative, so there is no surplus to distribute. All figures are computed from company filings; this is analysis, not investment advice.
Frequently asked
Does PolyPeptide Group (PPGN.XSWX) pay a dividend?+
No. PolyPeptide Group (PPGN.XSWX) does not currently pay a dividend. The last payment in our data was in 2021, and nothing has been paid since.
How does PolyPeptide Group return cash to shareholders?+
It largely does not. PolyPeptide Group pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.
Could PolyPeptide Group afford to pay a dividend?+
Not currently. PolyPeptide Group's free cash flow is negative at -€31 million, meaning the business consumed cash over the period rather than generating it. A company funding a dividend from cash it is not producing would be paying shareholders out of its balance sheet or borrowings, which is not sustainable.
Which healthcare companies do pay dividends?+
Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with PolyPeptide Group.
Peers
Drug Manufacturers - Specialty & Generic · Pick stocks to compare with PPGN.XSWX
Held by ETFs
PPGN.XSWX is in 4 US ETFs. The largest of them, with PPGN.XSWX's weight in each:
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing PPGN.XSWX
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.